Texas Tech Physicians Dermatology Offers Free Skin Cancer Screening
Prevent, Detect and Live
Could You Have Skin Cancer?

Free screenings offered Saturday, May 7
On Saturday, May 7, Texas Tech Physicians Department of Dermatology will host a free skin cancer screening at Southwest Cancer and Research Center.
According to the National Cancer Institute, skin cancer is the most common type
of cancer in the U.S., and melanoma is the most common cancer for young adults. When
caught early, skin cancer, including melanoma, is highly treatable.
The five-year survival rate for people whose melanoma is detected and treated before
it spreads to the lymph nodes is 98%.
Texas Tech Physicians dermatologists and other local dermatologists will discuss symptoms such as new moles that look different from other moles; new red or darker color flaky patches that may be a little raised; new flesh-colored firm bumps; change in the size, shape, color or feel of a mole; or sores that do not heal.
Skin examinations and referrals for subsequent treatment also will be provided. No appointments are needed.
This event will be held from 8 a.m. - 1 p.m. on Saturday, May 7 at the Southwest Cancer and Research Center located at 602 Indiana Ave in Lubbock. For more information, call Kathleen Harth at (806) 743-1842.
Related Stories
Stay Safe: Preventing Summertime Dehydration
As the summer heat continues to intensify, so does the risk for dehydration. Prioritizing hydration this summer can protect you and your loved ones from potentially life-threatening complications.
Gov. Abbott Reappoints Varma to Texas Medical Board
Gov. Greg Abbott recently reappointed Surendra Varma, M.D., to the Texas Medical Board (TMB) District Three Review Committee.
Labor of Love: More Women Turn to Nurse-Midwives for Healthcare
In hospitals, birth centers and private homes across the country, nurse-midwives are expanding women’s healthcare options.
Recent Stories
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.
From Backpacks to White Coats
TTUHSC School of Medicine Admissions Office team members delivered critical school supplies worth nearly $6,500 in total on Thursday, Aug. 6, to Bayless Elementary School.
